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Diseases of the pancreas and periampullary region form
an important clinical group of malignant and also benign
diseases which still carry relatively high morbidity and mor-
tality rates. Pancreatic ductal adenocarcinoma, in particular,
is associated with very poor outcome as the number of new
cases per year is just slightly higher than the number of deaths
from this disease. Therefore, treatment of these conditions
should always be based on both the highest level of evidence
and technical expertise.
Surgery for diseases of the pancreas and periampullary
region has evolved substantially during the last 15 years and
several new surgical techniques have been described. Accord-
ing to recent randomized trials and advances in medical
treatment, several surgical dogmas have been refuted.
The majority of patients with pancreatic and peri-
ampullary cancer at the time of diagnosis have advanced
disease. However, in specialized centers, 10–15% of the
patients with these malignances are suitable for resection. In
these centers, the morbidity and mortality associated with
major pancreatic resection have been reduced considerably in
recent years. It is an undisputed fact that pancreatic resection
ranks as one of the most, if not the most, complicated and
technically challenging surgical procedures. It not only is a
demanding technical exercise but also exerts a substantial
logistical strain on healthcare resources.
The group from Heidelberg addressed the importance
of vascular resections during pancreatic surgery. The limits
of resection in patients with pancreatic and periampullary
cancers have been extended. The recently published consen-
sus paper by the International Study Group for Pancreatic
Surgery (ISGPS) provided up-to-date definitions of border-
line and extended resections.These definitions help clinicians
worldwide to apply extended surgical approaches to an
increasing number of surgical candidates. These procedures
include vascular and multivisceral resections.
When dictated by tumor involvement, resection of portal
and superior mesenteric and splenic veins should be per-
formed routinely in patients if the patient’s general condition
allows and there are no major comorbidities. The decision
for arterial resections should be strictly individualized. This
type of surgery should be reserved for fit, younger patients,
with preoperative careful examination of all aspects of this
extended surgery. The majority of patients with infiltration
of coeliac trunk or superior mesenteric artery should be
considered for neoadjuvant therapy and then reevaluated for
postponed surgical intervention and resection of infiltrated
vessels.
D. Hartmann and H. Friess addressed the current status
of the role of the surgery in the treatment of chronic
pancreatitis. Surgical intervention in patients with chronic
pancreatitis is mainly performed to resolve the complications
of disease. In the majority of patients, intractable pain is the
major indication for surgery, although jaundice, duodenal
obstruction, and portal vein thrombosis are not rare. The
goal of the surgery is pain reduction and management
of complications, while preserving exocrine and endocrine
pancreatic function and improving quality of life. Timing of
surgery is an important feature during the prolonged natural
history of the disease. New findings support early surgery
for pain management in chronic pancreatitis patients, since
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early surgical intervention is associated with an improved
postoperative pain relief, a reduced risk of pancreatic insuffi-
ciency, and decreased reintervention rates in comparison to
conservative step-up approaches.
Duodenum-preserving pancreatic head resections (in-
cluding Beger, Frey, and Berne procedures) seem to be
superior in peri- and postoperative outcome parameters
and quality of life compared to partial pancreatoduodenec-
tomy (Whipple procedure) while being equally effective in
postoperative pain relief, overall health, and postoperative
endocrine sufficiency.
Organ-sparing operation at the right point of time carries
a better outcome than performing an extended resection as
a last resort once all therapeutic options are exhausted. An
early timing of surgical therapy is crucial for the outcome of
patients with painful CP and the indication of surgery should
be considered early once symptoms are unambiguous.
The group from Verona evaluated technical aspects,
indications, and results of the application of Radiofrequency
Ablation (RFA) and Irreversible Electroporation (IRE) on
locally advanced pancreatic cancer (LAPC).
RFA and IRE are the most frequently applied ablative
techniques for the management of locally advanced pancre-
atic cancer. These techniques are versatile, since they can be
performed at laparostomy, or via laparoscopic, endoscopic,
or percutaneous routes. It has been demonstrated that their
use is safe; however, since serious adverse events can occur,
they are best performed at high volume centers and by high
volume surgeons.
The application of RFA and IRE is recommended in a
multidisciplinary decision-making setting and they should
be used especially on locally advanced tumors that have not
demonstrated a propensity tometastasize.That said, properly
designed studies are still needed to assess their efficacy.
Finally, one of the most intriguing aspects of the appli-
cation of RFA and IRE is their presumed stimulation of the
immune system against the cancer. Once this aspect is further
clarified and possibly confirmed, their use within the natural
history of pancreatic cancer will become clearer. The group
fromGlasgowdescribed the treatment of infected necrotizing
pancreatitis. Treatment of acute pancreatitis is currently
based on the definitions set forth in the 2012 Revised Atlanta
Classification. Since the PANTER trial, there is now consen-
sus that a “step-up approach” starting with catheter drainage
and, if needed, followed by minimally invasive necrosectomy
is the preferred treatment approach to infected necrotizing
pancreatitis. The most commonly used minimally invasive
strategies for necrosectomy are transgastric necrosectomy,
percutaneous necrosectomy, and video-assisted retroperi-
toneal debridement (VARD). The recently completed TEN-
SION trial compared transgastric necrosectomy with VARD
within a “step-up approach,” but the final results are awaited.
The advantage of transgastric necrosectomy is that it min-
imizes the risk of a pancreatocutaneous fistula which can
be very problematic in case of “central gland necrosis.” The
major disadvantage of transgastric necrosectomy is that mul-
tiple, often lengthy, procedures are required, whereas, with
VARD via a 3–5 cm incision, only 1-2 procedures are suffi-
cient in the majority of patients. Percutaneous necrosectomy
probably holds themiddle ground between these two options
and several large series have described good outcomes.
The group from Belgrade overviewed the role of inter-
ventional treatment of abdominal compartment syndrome
(ACS) during severe acute pancreatitis (SAP). Some unre-
solved questions persist which include the role of medical
treatment and the indications for and the timing of interven-
tional techniques. Currently, there is no unanimity of opinion
regarding surgical or other interventional treatments for ACS
during the course of SAP.
Critically ill patients with acute pancreatitis have a con-
siderable risk for developing intra-abdominal hypertension.
Routine measurement of intra-abdominal pressure is rec-
ommended, allowing the identification of patients at risk of
abdominal compartment syndrome. First line therapy for
this life-threatening complication is conservative treatment
aiming to decrease IAP and to restore organ dysfunction.
If nonoperative measures are not effective, early abdominal
decompression ismandatory. Percutaneous catheter drainage
should be the first step in interventional treatment which can
relieve ACS. When ACS persists, surgery is indicated.
Timing of abdominal decompression also remains uncer-
tain in the treatment of these patients. However, the Finnish
group published their experience with 26 patients regarding
early and late decompression. Results clearly showed that
early decompression (first 4 days) was associated with a
significantly lower mortality rate, compared with late decom-
pression (after 4 days).
Midline laparostomy seems to be the method of choice,
although full-thickness transverse subcostal bilateral laparos-
tomy, subcutaneous linea alba fasciotomy, and fasciotomy of
the anterior rectus abdominis sheath have been described
as alternative options. Since laparostomy carries significant
morbidity, randomized studies are needed to establish firm
advantages over other techniques.
Better understanding of pathophysiology of diseases of
the pancreas and periampullary region has led surgeons to
change some traditional surgical approaches anddevelopnew
innovative techniques. Technological advances which have
improved the safety and efficacy of pancreatic surgery have
been performed mainly in selected high volume centers. In
order to improve both quality of life and duration of survival
for our patients, novel surgical techniques should become
more widely available and accepted. Studies with sound
design and statistical methodology are urgently needed.
In the present special issue, the authors have addressed
new understanding of the pathophysiology of diseases of
the periampullary region and pancreas. They have focused
their interest in evidence-based, novel surgical techniques
and approaches and challenging clinical settings have been
emphasized.
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